Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?
Levent F, Senoz O, Emren SV, Emren ZY, Gediz RB.
Herz. 2022 Feb;47(1):73-78. doi: 10.1007/s00059-021-05036-z. Epub 2021 Apr 24.
Long-term outcomes of IVUS-guided and angiography-guided drug-eluting stent implantation for left main coronary artery disease: a retrospective consort study.
Yang Q, Ma X, Wang Y.
J Cardiothorac Surg. 2024 Jul 1;19(1):407. doi: 10.1186/s13019-024-02800-0.
Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
Nairooz R, Saad M, Sardar P, Aronow WS.
Heart. 2017 Jul;103(14):1096-1103. doi: 10.1136/heartjnl-2016-310886. Epub 2017 Jan 23.
[Long-term prognosis of drug eluting stents implantation in elderly patients with unprotected left main coronary artery disease].
Pan Y, Qiu Q, Mu Y, Wu Z, Yu XP, He JQ.
Zhonghua Yi Xue Za Zhi. 2020 Jun 9;100(22):1720-1724. doi: 10.3760/cma.j.cn112137-20191030-02355.
Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
Eur J Cardiothorac Surg. 2017 May 1;51(5):943-949. doi: 10.1093/ejcts/ezw370.
Comparison of noninvasive follow-up testing in patients after percutaneous coronary intervention with drug-eluting stent implantation.
Seki T, Takeuchi M, Kawakami K.
J Cardiol. 2022 Sep;80(3):275-282. doi: 10.1016/j.jjcc.2022.05.001. Epub 2022 May 21.
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT Investigators.
N Engl J Med. 2016 Sep 29;375(13):1242-52. doi: 10.1056/NEJMoa1607991. Epub 2016 Aug 29.
Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting Stent Implantation.
Dai C, Chen Z, Fu J, Qian J, Ge J.
Thromb Haemost. 2020 May;120(5):857-865. doi: 10.1055/s-0040-1709520. Epub 2020 May 5.
Predictors of Irregular Protrusion After Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease.
Taguchi Y, Itoh T, Sasaki W, Oda H, Uchimura Y, Kaneko K, Sakamoto T, Goto I, Sakuma M, Ishida M, Terashita D, Otake H, Morino Y, Shinke T.
Int Heart J. 2022;63(2):210-216. doi: 10.1536/ihj.21-548.
